91 related articles for article (PubMed ID: 11161587)
1. Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells.
Chen ZY; Istfan NW
Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):67-73. PubMed ID: 11161587
[TBL] [Abstract][Full Text] [Related]
2. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
3. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
4. Control of E2F activity by p21Waf1/Cip1.
Delavaine L; La Thangue NB
Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
Khwaja F; Djakiew D
Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
[TBL] [Abstract][Full Text] [Related]
6. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases.
Pusch O; Bernaschek G; Eilers M; Hengstschläger M
Oncogene; 1997 Aug; 15(6):649-56. PubMed ID: 9264405
[TBL] [Abstract][Full Text] [Related]
7. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
[TBL] [Abstract][Full Text] [Related]
8. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
9. Role for E2F in DNA damage-induced entry of cells into S phase.
Huang Y; Ishiko T; Nakada S; Utsugisawa T; Kato T; Yuan ZM
Cancer Res; 1997 Sep; 57(17):3640-3. PubMed ID: 9288762
[TBL] [Abstract][Full Text] [Related]
10. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of E2F-1 induces cyclin A- and E-associated kinase activities independently from cell cycle position.
Soucek T; Pusch O; Hengstschläger-Ottnad E; Adams PD; Hengstschläger M
Oncogene; 1997 May; 14(19):2251-7. PubMed ID: 9178900
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
[TBL] [Abstract][Full Text] [Related]
14. E2F activity is biphasically regulated by androgens in LNCaP cells.
Hofman K; Swinnen JV; Verhoeven G; Heyns W
Biochem Biophys Res Commun; 2001 Apr; 283(1):97-101. PubMed ID: 11322773
[TBL] [Abstract][Full Text] [Related]
15. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
Chew YP; Ellis M; Wilkie S; Mittnacht S
Oncogene; 1998 Oct; 17(17):2177-86. PubMed ID: 9811449
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
17. E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53.
Pruschy M; Wirbelauer C; Glanzmann C; Bodis S; Krek W
Cell Growth Differ; 1999 Mar; 10(3):141-6. PubMed ID: 10099827
[TBL] [Abstract][Full Text] [Related]
18. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity.
Fabbrizio E; Le Cam L; Polanowska J; Kaczorek M; Lamb N; Brent R; Sardet C
Oncogene; 1999 Jul; 18(30):4357-63. PubMed ID: 10439043
[TBL] [Abstract][Full Text] [Related]
20. Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I.
Huang Y; Ohtani K; Iwanaga R; Matsumura Y; Nakamura M
Oncogene; 2001 Mar; 20(9):1094-102. PubMed ID: 11314046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
